↗1 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$47KSold on the market
1Companies
Aug 17, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 202616:06 | Aug 13, 2026 | DYNDyne Therapeutics, Inc. | Chief Financial Officer | S · Sell10b5-1 | $26.28 | −1,797 | 119,766 | -1% | −$47K |